| Stereochemistry | RACEMIC |
| Molecular Formula | C17H25NO2 |
| Molecular Weight | 275.3859 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@H]1CN(C)CC[C@]1(OC(=O)CC)C2=CC=CC=C2
InChI
InChIKey=ODEGQXRCQDVXSJ-WMLDXEAASA-N
InChI=1S/C17H25NO2/c1-4-14-13-18(3)12-11-17(14,20-16(19)5-2)15-9-7-6-8-10-15/h6-10,14H,4-5,11-13H2,1-3H3/t14-,17+/m0/s1
Alphameprodine (ACSCN 9604) is an opioid analgesic classified by the United States Drug Enforcement Administration under Schedule I of illegal substances. The stereoisomer betameprodine is similarly classified, however alphameprodine is more widely used (both are referred to as Meprodine). Alphameprodine is a structural analogue of meperidine. It exerts physiological effects characteristic of opioids, such as analgesia, euphoria and sedation, as well as itching, nausea, and respiratory depression.
Approval Year
PubMed
ACTIVE MOIETY
